Official Title
Variants of SARS-CoV-2 in Central and West Africa: Frequency of Circulating Viruses and Implications for the Management and Control of the Pandemic
Brief Summary

The main objective of this research is to identify and characterize the differentmolecular variants of SARS-CoV-2, emerging and / or circulating in several countries ofSub-Saharan Africa (Burkina Faso, Côte d'Ivoire, Gabon, Mali, Chad and Republic of Congo)and determine their role in the evolution of the pandemic.

Detailed Description

The main objective of this research is to identify and characterize the different
molecular variants of SARS-CoV-2, emerging and / or circulating in several countries of
Sub-Saharan Africa (Burkina Faso, Côte d'Ivoire, Gabon, Mali, Chad and Republic of Congo)
and determine their role in the evolution of the pandemic.

The research will combine retrospective and prospective approaches to determine the
evolutionary dynamics of the virus since the start of the pandemic. It is planned to
sequence the entire Spike protein gene for 1550 viruses and make 300 entire genomes. This
work will be supplemented by antibody seroneutralization and respiratory transcriptomics
tests, in order to estimate the immuno-virological response of the COVID-19 disease
associated with the identified SARS-CoV-2 variants.

Unknown status
COVID-19

Diagnostic Test: RT PCR

Characterize the different molecular variants of SARS-CoV-2, determine the escape
potential of the new variants from neutralization by monoclonal antibodies and currently
available vaccines and characterization of the mRNAs expressed in infected persons
Other Name: Sequencing of the S gene,Sequencing of the entire SARS-COV-2 genome,Seroneutralization of antibodies,Respiratory transcriptomics

Eligibility Criteria

Inclusion Criteria:

- Major subject (cf. country)

- Presenting for a SARS-COV-2 diagnosis, whether symptomatic or not

- Not objecting to participating in the research

Exclusion Criteria:

- NA

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: N/A
Countries
Burkina Faso
Chad
Congo
Côte D'Ivoire
Gabon
Mali
Locations

Centre de Référence pour les pathogènes émergents et réémergent
Bobo-Dioulasso, Burkina Faso

Centre Hospitalier Universitaire la Référence Nationale (CHU-RN)
N'Djamena, Chad

Laboratoire National de Santé Publique Brazzaville
Brazzaville, Congo

CIRBA
Abidjan, Côte D'Ivoire

Unité Mixte de Recherche CIRMF-SSM
Libreville, Gabon

SEREFO
Bamako, Mali

Not Provided

ANRS, Emerging Infectious Diseases
NCT Number
MeSH Terms
COVID-19